Capture Vascular | Capture Continues with New Clinical Cases for its MegaVacTM Mechanical Thrombectomy System-ATK
17825
single,single-post,postid-17825,single-format-standard,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Capture Continues with New Clinical Cases for its MegaVacTM Mechanical Thrombectomy System-ATK

Capture Continues with New Clinical Cases for its MegaVacTM Mechanical Thrombectomy System-ATK

Capture Vascular, Inc. (Capture) completed three successful clinical cases using its proprietary MegaVacTM Mechanical Thrombectomy System this past week.

The first case involved a 42-year-old male patient with a target treatment area of the right leg, above and below the knee. Overall the MegaVacTM Mechanical Thrombectomy System was noted that it worked both easy and well and the procedure was marked successful.

The second case involved a 62-year-old female patient with a target area of the left leg above the knee. Again the system was noted as working both easy and well where the procedure was not only successful, but the MegaVacTM Mechanical Thrombectomy System exceeded expectations.

The third case involved a 67-year-old male patient with a target area of the left leg, above and below the knee. The MegaVacTM Catheter and ThromboWireTM Clot Retractor both performed well with debris noted in the ThromboWireTM Clot Retractor after removal.

Capture will continue to perform clinical cases throughout the coming months as it focuses on adoption of the MegVacTM Mechanical Thrombectomy System-ATK. The expanded device description of the ATK builds off of Capture’s mechanical thrombectomy technology with key features such as centering and securing the occlusion funnel tip position within the vessel, and also being able to pass through other lesion disruptive devices through its lumen. With these updates, Capture’s MegaVacTM Mechanical Thrombectomy System can now provide proximal occlusion, a static work environment, and the removal of emboli and thrombi for even more situations.

“In working through recent clinical experiences we continually received feedback from physicians that they wanted to use Capture’s system as a proximal occlusion conduit for atherectomy systems, CTO crossing wires, balloons and stents,” says Eric Wells, CEO of Capture Vascular. “I’m particularly excited that the team was able to meet our customer’s needs and execute these device advances,” says Wells.

Founded in 2013, Capture’s proprietary technology includes the MegaVacTM Catheter with SafeSealTM Technology and the ThromboWireTM Clot Retractor, which makes up the MegaVacTM Mechanical Thrombectomy System. With a strong portfolio of 30 patents, Capture’s innovative system offers several unique features in one simple, efficient, and effective device.

About Telluride Medical Partners LLC
Headquartered in Telluride, CO, Telluride Medical Partners LLC was founded in 2016 by Eric Wells and is comprised of business and medical device startup experts and entrepreneurs focused on bringing disruptive medical devices and technologies to market. With a cohort of five medical technologies, Telluride Medical Partners is quickly expanding and serving clients worldwide. For more information visit www.telluridemedicalpartners.com.

No Comments

Sorry, the comment form is closed at this time.